Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Therapeutic Effects of Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19

NCT04470297 is registered in ClinicalTrials.gov with Associação Fundo de Incentivo à Pesquisa as lead sponsor.

NCT NCT04470297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04470297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Therapeutic Effects of Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19
Lead sponsor
Associação Fundo de Incentivo à Pesquisa
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2020
Completion date
March 31, 2021
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, lung injury